Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
56.6M
-
Shares change
-
-146
-
Total reported value, excl. options
-
$161M
-
Value change
-
-$938K
-
Put/Call ratio
-
0.73
-
Number of buys
-
61
-
Number of sells
-
-56
-
Price
-
$2.84
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q1 2024
138 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q1 2024.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.6M shares
of 127M outstanding shares and own 44.6% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (11.5M shares), Soleus Capital Management, L.P. (9.57M shares), BlackRock Inc. (4.97M shares), VANGUARD GROUP INC (3.54M shares), ACADIAN ASSET MANAGEMENT LLC (3M shares), DEUTSCHE BANK AG\ (2.51M shares), GEODE CAPITAL MANAGEMENT, LLC (1.75M shares), DIMENSIONAL FUND ADVISORS LP (1.7M shares), STATE STREET CORP (1.45M shares), and AQR CAPITAL MANAGEMENT LLC (1.28M shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.